OVERVIEW

Webcast From Improving Outcomes in Gynecologic Cancers is organized by prIME Oncology. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

Dates:
Release Date: Jul 12, 2019
Expiration Date: Jul 12, 2020

Target Audience:
This activity is intended for gynecologic oncologists, medical oncologists, oncology nurses, and other members of the cancer care team involved in the management of gynecologic malignancies.

Learning Objectives:
After successful completion of this educational activity, participants should be able to:
• Incorporate PARP inhibitors into treatment regimens for patients with ovarian cancer
• Devise effective strategies for treating patients with ovarian and cervical cancer with checkpoint inhibitors and PARP inhibitors, both alone or in combination
• Describe safety and efficacy data of PARP inhibition and immunotherapy in endometrial cancer

Additional details will be posted as soon as they are available.